Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Matthias Dürst

Professor, Head research laboratory

Universitätsklinikum Jena

Germany

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Inorganic Chemistry

20%

Pharmaceutical Chemistry

20%

Metal Chemistry

20%

Metalloenzyme

20%

Case-control Study

20%

Ovarian Cancer

20%

Coordination Chemistry

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles8

Heterogeneous Distribution of Human Papillomavirus (HPV) Integration Sites in Cervical Precancers Compromises the Diagnostic Accuracy of Integrant-Specific PCR

Article Link

Year:

2025

Accuracy of GynTect® Methylation Markers to Detect Recurrent Disease in Patients Treated for CIN3: A Proof-of-Concept Case-Control Study

Article Link

Year:

2024

Evaluation of CIN2/3 Lesion Regression in GynTect® DNA Methylation-Marker-Negative Patients in a Longitudinal Study

Article Link

Year:

2023

Novel Nickel(II), Palladium(II), and Platinum(II) Complexes with O,S Bidendate Cinnamic Acid Ester Derivatives: An In Vitro Cytotoxic Comparison to Ruthenium(II) and Osmium(II) Analogues

Article Link

Year:

2022

Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms

Article Link

Year:

2022

Evidence for disseminated tumor cells in lymphatic vessels afferent to sentinel lymph nodes in patients diagnosed with cervical cancer

Article Link

Year:

2021

Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance

Article Link

Year:

2021

RUNX3 Transcript Variants Have Distinct Roles in Ovarian Carcinoma and Differently Influence Platinum Sensitivity and Angiogenesis

Article Link

Year:

2021

Collaborators2

Alexander S. Mosig

Jena University Hospital

GERMANY

Peter Hillemanns

Prof. Dr.

Medizinische Hochschule Hannover

GERMANY

How do I reach out?

Meet Kite AI

Matthias Dürst

Professor, Head research laboratory

How do I reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Articles8

Heterogeneous Distribution of Human Papillomavirus (HPV) Integration Sites in Cervical Precancers Compromises the Diagnostic Accuracy of Integrant-Specific PCR

Accuracy of GynTect<sup>®</sup> Methylation Markers to Detect Recurrent Disease in Patients Treated for CIN3: A Proof-of-Concept Case-Control Study

Evaluation of CIN2/3 Lesion Regression in GynTect<sup>®</sup> DNA Methylation-Marker-Negative Patients in a Longitudinal Study

Novel Nickel(II), Palladium(II), and Platinum(II) Complexes with <i>O</i>,<i>S</i> Bidendate Cinnamic Acid Ester Derivatives: An In Vitro Cytotoxic Comparison to Ruthenium(II) and Osmium(II) Analogues

Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms

Evidence for disseminated tumor cells in lymphatic vessels afferent to sentinel lymph nodes in patients diagnosed with cervical cancer

Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance

RUNX3 Transcript Variants Have Distinct Roles in Ovarian Carcinoma and Differently Influence Platinum Sensitivity and Angiogenesis

Collaborators2

Alexander S. Mosig

Peter Hillemanns

How do I reach out?